These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7398992)

  • 1. Detection of sclerosis-inducing glycosaminoglycan in the skin of an amine-induced experimental skin sclerosis.
    Ishikawa H; Yamakage A; Kitabatake M; Katayama H; Saito Y
    Dermatologica; 1980; 161(3):145-51. PubMed ID: 7398992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of scleroderma-inducing glycosaminoglycan.
    Ishikawa H; Kitabatake M; Akiyama F
    Acta Derm Venereol; 1988; 68(5):378-84. PubMed ID: 2461019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma-inducing glycosaminoglycan in the urine of patients with systemic scleroderma.
    Ishikawa H; Saito Y; Yamakage A; Kitabatake M
    Dermatologica; 1978; 156(4):193-204. PubMed ID: 564296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to experimental scleroderma, using urinary glycosaminoglycans from patients with systemic scleroderma.
    Ishikawa H; Suzuki S; Horiuchi R; Sato H
    Acta Derm Venereol; 1975; 55(2):97-107. PubMed ID: 48324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational scleroderma-like disorder occurring in men engaged in the polymerization of epoxy resins.
    Yamakage A; Ishikawa H; Saito Y; Hattori A
    Dermatologica; 1980; 161(1):33-44. PubMed ID: 7398975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte responsiveness to urinary glycosaminoglycan in systemic scleroderma.
    Ishikawa H; Hattori A
    Dermatologica; 1979; 158(5):328-33. PubMed ID: 312217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.
    Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K
    J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure to demonstrate fibrotic changes in the skin of mice injected with glycosaminoglycan fractions from the urine of scleroderma patients.
    Fox PK; White DD; Cavanagh M; Davies MG; Wusterman F
    Dermatologica; 1982 Feb; 164(2):90-4. PubMed ID: 7075853
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disaccharide analysis of the skin glycosaminoglycans in systemic sclerosis.
    Akimoto S; Hayashi H; Ishikawa H
    Br J Dermatol; 1992 Jan; 126(1):29-34. PubMed ID: 1536759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligosaccharide modification by N-acetylglucosaminyltransferase-V in macrophages are involved in pathogenesis of bleomycin-induced scleroderma.
    Kato A; Yutani M; Terao M; Kimura A; Itoi S; Murota H; Miyoshi E; Katayama I
    Exp Dermatol; 2015 Aug; 24(8):585-90. PubMed ID: 25876794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in skin disaccharide components correlate with the severity of sclerotic skin in systemic sclerosis.
    Higuchi T; Ohnishi K; Hayashi H; Ishikawa O; Miyachi Y
    Acta Derm Venereol; 1994 May; 74(3):179-82. PubMed ID: 7915457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scleroderma and scleroderma-like diseases caused by environmental pollutants].
    Haustein UF; Ziegler V
    Derm Beruf Umwelt; 1986; 34(3):61-7. PubMed ID: 2427299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
    Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H
    Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of glycosaminoglycans (heparan sulfate) from glomerular basement membranes.
    Kanwar YS; Farquhar MG
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4493-7. PubMed ID: 159457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes in the content and composition of glycosaminoglycans isolated from the mouse skeletal muscle: normal and dystrophic conditions.
    Watanabe K; Oohira A; Uramoto I; Totsuka T
    J Biochem; 1986 Jul; 100(1):167-73. PubMed ID: 3759927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of atrophoderma of Pasini and Pierini: analysis of glycosaminoglycan of the lesional skin.
    Tajima S; Sakuraoka K
    J Dermatol; 1995 Oct; 22(10):767-9. PubMed ID: 8586758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circumscribed myxoedema of lichen myxoedematosus as a sign of faulty formation of the proteoglycan macromolecule.
    Maeda H; Ishikawa H; Ohta S
    Br J Dermatol; 1981 Sep; 105(3):239-45. PubMed ID: 7272204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies on the reaction of acid mucopolysaccharide in sclerosis of the skin after betatron radiation, in scleroderma and some sclerosing dermatoses].
    Ishikawa H; Thies W; Schumacher W; Klaschka F
    Hautarzt; 1967 Apr; 18(4):174-80. PubMed ID: 4171962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.